leading to either obliteration or filling defects within the nodes; even large defects are sometimes almost impossible to assess accurately at the initial examination.
McDonald (1969) stressed that lymphangiography is no substitute for histology, but adequate biopsy confirmation or denial of suspected findings is not always readily forthcoming. Furthermore, a gland reacting to the presence of Lipiodol within it must surely pose some problems to the histologist in the doubtful case.
Nevertheless, lymphangiography is undoubtedly of great potential value in most cases of lymphoreticular disease and in some cases of carcinoma in particular sites. The interpretative difficulties should be well recognized and an attitude of watchful expectancy should be adopted in all doubtful appearances. Tumour localization in radiotherapy is considered as the whole process from the actual localization through treatment planning and field checking to the treatment itself. Typical schemes were discussed for head and neck and pelvic tumours and likely sources of error indicated. The importance of maintaining accuracy into the treatment stage is stressed as so often the initial localization and planning receive far more attention than the treatment set-up itself. Reliable information concerning the accuracy of the set-up is difficult to obtain, although Van de Geign (1972) has attempted to record consistency of set-up using a television camera system. His results as yet are not encouraging due to instability in the television imaging system.
Computer control in the treatment process was discussed and felt to be useful for checking some treatment parameters. However, completely automated treatment set-up systems would need to prove themselves in a very positive way to warrant their introduction as their associated disadvantages are considerable. The greatest of these is that the therapy radiographer would hand over a large part of her responsibility to a noni-thinking computer system. The first area is in radioisotope bone scanning. The traditional assessment of the skeleton for possible metastatic tumour involvement is by a radiological skeletal survey. This, however, is known to be relatively insensitive since a considerable amount of bone destruction may occur before it is radiologically visible. It has been shown that radioisotope bone scanning will indicate areas of new bone formation in the region of metastatic deposits before they are visible on X-rays (Charkes et al. 1964 , Galasko et al. 1968 ).
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The use of such a diagnostic survey will obviously result in a different staging of tumours. Nevertheless, bone scanning is not widely practised in this country. This is in part due to lack of suitable detecting instruments but also due to lack of a suitable, readily available isotope which will allow examination of the whole skeleton. Fluorine-18 answers this purpose, but is at the moment only available near a cyclotron.
Subramanian & McAfee (1971) described a new bone scanning agent, a complex of tripolyphos-
